In August 2002, the FDA announced the Pharmaceutical CGMPs for the 21st Century Initiative . The Agency’s stated intent was to integrate quality systems and risk management approaches into its existing programs with the goal of encouraging industry to adopt modern and innovative manufacturing technologies.